Litigation Details for Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-11-26 |
| Court | District Court, D. Delaware | Date Terminated | 2022-12-14 |
| Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,376,487 | ||
| Link to Docket | External link to docket | ||
Details for Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-11-26 | 1 | Complaint | or more claims of Vanda’s U.S. Patent No. 10,376,487 (“the ’487 patent”), which, in relevant part, generally… V. THE PATENT-IN-SUIT (U.S. PATENT NO. 10,376,487) … ’487 patent, entitled “Method of Treatment.” The USPTO duly and legally issued the ’487 patent on August… ’487 patent is attached to this Complaint as Exhibit A. 25. The ’487 patent generally…is covered by the ’487 patent, and Vanda has the right to enforce the ’487 patent and sue for infringement | External link to document |
| 2019-11-26 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487. (mal) (Entered: 11…26 November 2019 1:19-cv-02202 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-12-31 | 8 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487 AMENDED. (Fahnestock…26 November 2019 1:19-cv-02202 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
